Back
Intellia Therapeutics Vs. Smith-Midland Industry Stock Comparison
Sell
29
NTLA
Intellia Therapeutics
Last Price:
22.53
Seasonality Move:
-1.88%
Buy
53
SMID
Smith-Midland
Last Price:
37.12
Seasonality Move:
6.8%
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $22.55. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Smith-Midland (SMID)
is a Buy
Is Smith-Midland a Buy, Sell or Hold?
- The current Smith-Midland [SMID] share price is $36.62. The Score for SMID is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SMID is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $22.55
The current trend is relatively stagnant and NTLA is experiencing slight buying pressure.
SMID Stock Price Chart
What is Smith-Midland's stock price today?
-
The Smith-Midland share price today is $36.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMID is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 53.03 | Buy |
| Chaikin Money Flow: | 190907 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.84 - 23.26) | Buy |
| Bollinger Bands (100): | (21.71 - 25.41) | Sell |
SMID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 61.07 | Buy |
| Chaikin Money Flow: | 30842 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.64 - 34.92) | Buy |
| Bollinger Bands (100): | (29.7 - 36.08) | Buy |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.84 | Buy |
| 20-day SMA: | 21.91 | Buy |
| 50-day SMA: | 23.38 | Sell |
| 200-day SMA: | 25.58 | Sell |
| 8-day EMA: | 21.45 | Buy |
| 20-day EMA: | 21.77 | Buy |
| 50-day EMA: | 22.72 | Sell |
| 200-day EMA: | 26.12 | Sell |
SMID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.87 | Buy |
| 20-day SMA: | 33.22 | Buy |
| 50-day SMA: | 31.84 | Buy |
| 200-day SMA: | 36.39 | Buy |
| 8-day EMA: | 33.85 | Buy |
| 20-day EMA: | 32.95 | Buy |
| 50-day EMA: | 32.52 | Buy |
| 200-day EMA: | 32.78 | Buy |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.20 per share.
Smith-Midland Earnings Growth & SMID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intellia Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Smith-Midland Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||